Predicted protein targets (top 11)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MMP1 | P03956 | 12/20 | 0.61 |
| ▸ | MMP13 | P45452 | 9/20 | 0.61 |
| ▸ | MMP9 | P14780 | 6/20 | 0.61 |
| ▸ | ADAM17 | P78536 | 3/20 | 0.61 |
| ▸ | MMP2 | P08253 | 8/20 | 0.59 |
| ▸ | MMP3 | P08254 | 7/20 | 0.59 |
| ▸ | PDE4A | P27815 | 3/20 | 0.59 |
| ▸ | PDE4B | Q07343 | 3/20 | 0.59 |
| ▸ | PDE4C | Q08493 | 3/20 | 0.59 |
| ▸ | PDE4D | Q08499 | 3/20 | 0.59 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.48 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL7212138 | 0.91 | MMP13 (0.54) | MMP1MMP13MMP9ADAM17MMP2 | |
| SCHEMBL4968246 | 0.84 | MMP1 (0.48) | MMP1MMP13MMP9ADAM17MMP2 | |
| SCHEMBL7346604 | 0.82 | MMP13 (0.75) | MMP1MMP13MMP9ADAM17MMP2 | |
| SCHEMBL6928909 | 0.82 | MMP13 (0.75) | MMP1MMP13MMP9ADAM17MMP2 | |
| SCHEMBL6933212 | 0.79 | MMP13 (0.74) | MMP1MMP13MMP9ADAM17MMP2 | |
| Hydroxyamine SCHEMBL8224643 | 0.78 | PDE4A (0.50) | MMP1MMP13MMP9MMP2MMP3 | |
| SCHEMBL20444027 | 0.76 | MMP1 (0.72) | MMP1MMP13MMP9ADAM17MMP2 | |
| SCHEMBL7207035 | 0.76 | MMP1 (0.54) | MMP1MMP13MMP9MMP2MMP3 | |
| SCHEMBL6927179 | 0.76 | MMP1 (1.00) | MMP1MMP13MMP9ADAM17MMP2 | |
| SCHEMBL1847769 | 0.76 | MMP1 (1.00) | MMP1MMP13MMP9ADAM17MMP2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-0939628-B1 | THIOL SULFONE METALLOPROTEASE INHIBITORS | MONSANTO CO (US) | 2003-03-05 | — | — | EP | disclosed |
| US-6013649-A | BOND DISORDERS; AUTOIMMUNE DISEASES; ANTITUMOR AGENTS | MONSANTO COMPANY (US) | 2000-01-11 | — | — | US | disclosed |
| EP-0939628-A4 | THIOL SULFONE METALLOPROTEASE INHIBITORS | MONSANTO CO (US) | 1999-12-22 | — | — | EP | disclosed |
| EP-0939628-A1 | THIOL SULFONE METALLOPROTEASE INHIBITORS | MONSANTO COMPANY (US) | 1999-09-08 | — | — | EP | disclosed |
| WO-1998003164-A1 | THIOL SULFONE METALLOPROTEASE INHIBITORS | MONSANTO COMPANY (US) | 1998-01-29 | — | — | WO | disclosed |